Actinium Pharmaceuticals, Inc.ATNMNYSE

Revenue (LTM)

-100.0% YoY

Net Income (LTM)

$-38M

+21.7% YoY

Free Cash Flow

$-33M

Revenue CAGR (5Y)

—

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	1	1↓10.0%	0↓92.1%	0
Gross Profit	-0	1↑238.7%	1↑66.1%	0↓92.1%	-1↓1101.2%
Operating Income	-22	-25↓11.5%	-34↓36.6%	-52↓52.2%	-42↑18.9%
Net Income	-22	-25↓11.5%	-33↓33.3%	-49↓47.9%	-38↑21.7%
EBITDA	-22	-24↓11.4%	-33↓37.8%	-51↓53.1%	-37↑26.8%
EPS Diluted	-1.83	-1.20↑34.4%	-1.37↓14.2%	-1.83↓33.6%	-1.27↑30.6%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	64	78↑22.4%	109↑39.9%	77↓29.6%	73↓4.9%
Total Current Assets	65	80↑22.8%	111↑39.1%	78↓29.5%	75↓4.8%
Total Assets	66	80↑21.1%	114↑42.1%	81↓28.7%	77↓5.6%
Total Current Liabilities	5	7↑43.5%	11↑55.4%	8↓20.1%	8↓4.1%
Total Liabilities	5	7↑34.8%	48↑597.2%	45↓5.5%	44↓2.1%
Total Equity	61	74↑19.9%	66↓9.6%	36↓45.3%	33↓10.0%
Total Debt	1	0↓58.0%	3↑732.6%	2↓18.1%	2↓25.6%
Net Debt	-63	-78↓23.3%	-106↓37.2%	-75↑29.9%	-71↑4.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-22	-21↑3.5%	9↑141.4%	-47↓647.6%	-33↑30.1%
Capital Expenditure	-0	-0↑47.4%	-0↓175.2%	-0↑58.2%	-0↑92.8%
Free Cash Flow	-22	-21↑4.0%	8↑139.4%	-47↓673.7%	-33↑30.3%
Stock-Based Comp	1	2↑35.1%	3↑65.0%	4↑37.5%	5↑37.7%
Net Change in Cash	54	14↓73.8%	31↑120.7%	-33↓204.0%	-4↑88.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance